As ARID1A mutations can already be observed in early bladder cancer lesions, it is important to address the consequences of ARID1A deregulation as it might help to understand how early lesions progress towards muscle‐invasive disease with poor prognosis [15, 23, 43]. This evidence concerns the gene ARID1A and urinary bladder cancer.